Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Competition Heats Up For Beijing’s Vaccine Market

This article was originally published in PharmAsia News

Executive Summary

Beijing, the first city to initiate free hepatitis A vaccination for children under China's nationwide immunity plan, has given the green light to GlaxoSmithKline and local enterprise Sinovac Biotech to provide inactivated hepatitis A vaccine. The two companies will effectively corner the Beijing free hepatitis A vaccine market for three years. According to public information, Sanofi Pasteur, GSK and Merck Sharpe & Dhome supply half of the paid vaccine market in the city. Officials at the China Association of Pharmaceutical Commerce believe foreign corporations will face fierce competitive bidding from domestic companies. Last year, Sanofi Pasteur was the only multinational company out of five pharmaceutical firms who won the tender for supplying Beijing with flu vaccine. (Click here for more - Chinese Language)

You may also be interested in...

Ironwood Ends Phase III GERD Program, Will Cut 100 Jobs

The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.

FDA Finalizes Guidance On Blood Glucose Meters With Separate Documents For OTC, Rx Devices

The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.

Hahn Praises CDRH Staff For Mitigating COVID-19 Deaths

The US FDA commissioner published a blog post commending and highlighting the work device center staff have done during the pandemic to speed tests and devices to market to save lives.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts